Literature DB >> 19237935

Erythropoietin in sepsis: a new use for a familiar drug?

Amy C Fox, Craig M Coopersmith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19237935      PMCID： PMC2675573          DOI： 10.1097/CCM.0b013e318196fd23

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  12 in total

1.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 2.  Management of sepsis.

Authors:  James A Russell
Journal:  N Engl J Med       Date:  2006-10-19       Impact factor: 91.245

3.  Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.

Authors:  Howard L Corwin; Andrew Gettinger; Ronald G Pearl; Mitchell P Fink; Mitchell M Levy; Marc J Shapiro; Michael J Corwin; Theodore Colton
Journal:  JAMA       Date:  2002-12-11       Impact factor: 56.272

Review 4.  The disconnect between animal models of sepsis and human sepsis.

Authors:  Daniel Rittirsch; L Marco Hoesel; Peter A Ward
Journal:  J Leukoc Biol       Date:  2006-10-04       Impact factor: 4.962

5.  Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture.

Authors:  D G Remick; D E Newcomb; G L Bolgos; D R Call
Journal:  Shock       Date:  2000-02       Impact factor: 3.454

6.  Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality.

Authors:  Marcin F Osuchowski; Kathy Welch; Javed Siddiqui; Daniel G Remick
Journal:  J Immunol       Date:  2006-08-01       Impact factor: 5.422

7.  Therapeutic effects of erythropoietin in murine models of endotoxin shock.

Authors:  Kazutetsu Aoshiba; Shigemitsu Onizawa; Takao Tsuji; Atsushi Nagai
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

Review 8.  Beneficial and ominous aspects of the pleiotropic action of erythropoietin.

Authors:  Wolfgang Jelkmann; Klaus Wagner
Journal:  Ann Hematol       Date:  2004-08-21       Impact factor: 3.673

9.  Efficacy and safety of epoetin alfa in critically ill patients.

Authors:  Howard L Corwin; Andrew Gettinger; Timothy C Fabian; Addison May; Ronald G Pearl; Stephen Heard; Robert An; Peter J Bowers; Paul Burton; Mark A Klausner; Michael J Corwin
Journal:  N Engl J Med       Date:  2007-09-06       Impact factor: 91.245

10.  Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.

Authors:  C G Winearls; D O Oliver; M J Pippard; C Reid; M R Downing; P M Cotes
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321
View more
  1 in total

1.  Effects of continuous erythropoietin receptor activator in sepsis-induced acute kidney injury and multi-organ dysfunction.

Authors:  Camila E Rodrigues; Talita R Sanches; Rildo A Volpini; Maria H M Shimizu; Patrícia S Kuriki; Niels O S Camara; Antonio C Seguro; Lúcia Andrade
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.